Press Releases Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Delayed Nasdaq Other stock markets 04:00:00 2024-06-03 pm EDT			5-day change	1st Jan Change
4.77 ^USD	+5.30%		+5.53%	-15.12%

Mar. 15	Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI
Mar. 13	Craig-Hallum Downgrades Champions Oncology to Hold From Buy	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation	Mar. 08	AQ
Champions Oncology, Inc.	Nov. 02	AQ
Champions Oncology Announces the Addition of Brady Davis as President	23-10-18	AQ
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K	23-09-13	PU
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	23-08-02	AQ
CHAMPIONS ONCOLOGY, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	23-04-05	AQ
CHAMPIONS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-03-16	AQ
Champions Oncology : Reports Record Quarterly Revenue of $14.3 Million	22-12-14	PU
CHAMPIONS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-12-13	AQ
Champions Oncology : Submission of Matters to a Vote of Security Holders - Form 8-K	22-10-20	PU
CHAMPIONS ONCOLOGY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-10-20	AQ
CHAMPIONS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-09-12	AQ
Champions Oncology : Reports Record Quarterly Revenue of $13.7 Million	22-09-09	PU
CHAMPIONS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-07-22	AQ
Champions Oncology : Reports Quarterly Revenue of $12.9 Million - Form 8-K	22-07-21	PU
Champions Oncology : Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics	22-05-31	PU
LIfT BioSciences N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoids compared to Keytruda	22-04-06	AQ
Champions Oncology : Reports Record Quarterly Revenue of $13.2 Million	22-03-16	PU
Champions Oncology : Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million	22-03-15	PU
CHAMPIONS ONCOLOGY, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-03-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Press Releases

Filters